Sunil Shah Overview

  • Primary Position
  • Co-Founder & Cha...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 10

  • Med. Deal Size

  • Med. Valuation

Sunil Shah General Information

Biography

Mr. Sunil Shah is a Co-Founder and serves as Managing Partner of Therapeutics at O2h Ventures. He serves as a Board Member at Oppilotech, Stingray Bio, and Oxford Drug Design. He also served as a Board Member at Visibly. He is a Co-Founder and serves as a Board Member at Five Alarm Bio. He serves as a Board Member at Kuano and In4Derm. He co-founded Iota Pharmaceuticals. He served as Chief Executive Officer and Board Member at Opal Oncology. He serves as the Chairman of Exonate. He served as Chief Executive Officer at Oxygen BioResearch. He is a serial entrepreneur having begun a career in the Life Sciences team at PA Consulting Group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). He serves as Executive Chairman at Alevin Therapeutics. He has a degree in Biochemistry and an MBA from Cambridge University.

Contact Information

Primary Position
Co-Founder & Chairman, CamGene Therapeutics
Education
Cambridge University, MBA (Master of Business Administration)
University of Keele, BS (Bachelor of Science)
Gender
Male
Email
su
Address
  • Hauxton House Mill
  • Scitech Park Mill Lane, Hauxton
  • Cambridge CB22 5HX
  • England, United Kingdom

Sunil Shah Positions (5)

Firm name Firm type Title Location Industry Since
Alevin Therapeutics Company Executive Chairman Cambridge, United Kingdom Drug Discovery
CamGene Therapeutics Company Co-Founder & Chairman Cambridge, United Kingdom Biotechnology
Five Alarm Bio Company Co-Founder & Board Member Cambridge, United Kingdom Drug Discovery
o2h Company Co-Founder Cambridge, United Kingdom Drug Discovery
O2h Ventures Investor Co-Founder & Managing Partner, Therapeutics Cambridge, United Kingdom Venture Capital

Sunil Shah Board Seats (10)

Company Industry Ownership Status Financing Status Location Since
Alevin Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
CamGene Therapeutics Biotechnology Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Exonate Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Five Alarm Bio Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Kuano Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom

Sunil Shah Lead Partner on Deals (23)

Sunil Shah has been the lead partner on 23 deals. Their latest deal was with Monument Therapeutics, a drug discovery company. The deal was made for on 25-Feb-2025.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Monument Therapeutics 25-Feb-2025 Later Stage VC Completed Drug Discovery Macclesfield, United Kingdom
Atelerix 28-Jan-2025 Completed Biotechnology Newcastle upon Tyne, United Kingdom
Revolver Therapeutics 15-Nov-2024 Completed Biotechnology Bath, United Kingdom
Kuano 13-Sep-2023 Completed Drug Discovery Cambridge, United Kingdom
ViaNautis 06-Jul-2023 Completed Biotechnology Cambridge, United Kingdom
Five Alarm Bio 27-Feb-2023 Completed Drug Discovery Cambridge, United Kingdom
Alevin Therapeutics 29-Jul-2022 Completed Drug Discovery Cambridge, United Kingdom
Oxford Drug Design 19-May-2022 Completed Drug Discovery Oxford, United Kingdom
Neurocentrx 12-May-2022 Later Stage VC Completed Pharmaceuticals Edinburgh, United Kingdom
Tay Therapeutics 03-Nov-2021 Early Stage VC Completed Drug Discovery Dundee, United Kingdom

Sunil Shah Network (121)

Board Members (49)

Name Company Representing Location From
Paul Finn Ph.D Oxford Drug Design Oxford Drug Design Oxford, United Kingdom
Alan Roth Ph.D Oxford Drug Design Oxford Drug Design Oxford, United Kingdom
Alevin Therapeutics Self Cambridge, United Kingdom
Kuano Kuano Cambridge, United Kingdom
Oppilotech Oppilotech London, United Kingdom

Portfolio Executives (72)

Name Company Role Deal date Location
Kiri Granger Ph.D Monument Therapeutics Chief Scientific Officer & Board Member 25-Feb-2025 Macclesfield, United Kingdom
Steve Plant Monument Therapeutics Chief Financial Officer 25-Feb-2025 Macclesfield, United Kingdom
Monument Therapeutics Co-Founder & Chief Development Officer 25-Feb-2025 Macclesfield, United Kingdom
Monument Therapeutics Co-Founder, Chief Executive Officer & Board Member 25-Feb-2025 Macclesfield, United Kingdom
Monument Therapeutics Advisory Board 25-Feb-2025 Macclesfield, United Kingdom

Sunil Shah Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
O2h Therapeutics EIS Fund O2h Ventures Venture - General Closed 2020

Sunil Shah FAQs

  • Who is Sunil Shah?

    Mr. Sunil Shah is a Co-Founder and serves as Managing Partner of Therapeutics at O2h Ventures.

  • How much does Sunil Shah typically invest?

    Sunil Shah's median deal size is .

  • What is Sunil Shah’s main position?

    Sunil Shah’s primary position is Co-Founder & Chairman.

  • How many active board seats does Sunil Shah hold?

    Sunil Shah holds 10 board seats including Alevin Therapeutics, CamGene Therapeutics, Exonate, Five Alarm Bio, and Kuano.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »